Related content

Deleterious CHEK2 1100delC and L303X mutants identified among 38 human breast cancer cell lines

By Wasielewski Marijke   Hanifi-Moghaddam Pejman   Hollestelle Antoinette   Merajver Sofia   Ouweland Ans   Klijn Jan   Ethier Stephen   Schutte Mieke  

Breast Cancer Research and Treatment, Vol. 113, Iss. 2, 2009-01 ,pp. : 285-291

Springer Publishing Company

Access to resources Recommend Favorite

Pathology of breast cancer in women with constitutional CHEK2 mutations

By Huzarski Tomasz  

Breast Cancer Research and Treatment, Vol. 90, Iss. 2, 2005-03 ,pp. : 187-189

Springer Publishing Company

Access to resources Recommend Favorite

Novel germline mutations in BRCA2 gene among breast and breast-ovarian cancer families from Poland

By Balabas Aneta   Skasko Elzbieta   Nowakowska Dorota   Niwinska Anna   Blecharz Pawel  

Familial Cancer, Vol. 9, Iss. 3, 2010-09 ,pp. : 267-274

Springer Publishing Company

Access to resources Recommend Favorite

The CHEK2 1100delC allele is not relevant for risk assessment in HNPCC and HBCC Spanish families

By Sánchez de Abajo Ana   Hoya Miguel   Godino Javier   Furió Vicente   Tosar Alicia   Pérez-Segura Pedro   Díaz-Rubio Eduardo   Caldés Trinidad  

Familial Cancer, Vol. 4, Iss. 2, 2005-06 ,pp. : 183-186

Springer Publishing Company

Access to resources Recommend Favorite

Novel germline mutations in BRCA2 gene among 96 hereditary breast and breast–ovarian cancer families from Kerala, South India

By Syamala Vani   Sreeja Leelakumari   Syamala Volga   Vinodkumar B.   Raveendran Praveenkumar   Sreedharan Hariharan   Kuttappan Ratheesan   Balakrishnan Lekshmi   Ankathil Ravindran  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 11, 2007-11 ,pp. : 867-874

Springer Publishing Company

Access to resources Recommend Favorite